Corindus Vascular Robotics (Formerly known as Corindus)
309 Waverley Oaks Road
111 articles with Corindus Vascular Robotics (Formerly known as Corindus)
Corindus CorPath GRX System Successfully Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019
Case broadcast live to thousands of EuroPCR attendees from Clinique Pasteur in France
Company will highlight CorPath GRX capabilities in complex vascular procedures
Corindus to Present “Evolution of Robotics: Automation, Remote Applications, and Beyond” at SCAI 2019 Breakfast Symposium on May 21, 2019
Company to feature latest milestones and technology advancements in vascular robotics at SCAI 2019
Eleven purchase orders for CorPath GRX Systems as adoption grows
Chesapeake Regional Medical Center installs CorPath® GRX Vascular Robotic Systems in all catheterization labs
Corindus Vascular Robotics, Inc. announced that it will release first quarter 2019 financial and business results on Tuesday, May 7, 2019 after the close of the U.S. financial markets.
Japan represents one of the largest markets for PCI globally, with over 1,200 hospitals performing nearly 250,000 PCI procedures annually
Corindus Vascular Robotics Files Required Registration Statement for Holders of Recently Completed $19.8 Million Private Placement
Shares sold in private placement are subject to contractual six-month lock-up
The Company intends to use the proceeds for general corporate purposes.
Submitted Neurovascular Indication Marking Important Step toward Addressing Stroke Market; Raised $19.8 Million to Fund Ongoing Innovation
Corindus Vascular Robotics, Inc., a leading developer of precision vascular robotics, announced that Mark Toland, President and Chief Executive Officer, will present at the 39th Annual Cowen Health Care Conference as follows
The net proceeds are expected to be approximately $14.8 million.
Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System
Expansion of CorPath GRX into neurovascular intervention could mark first step in revolutionizing stroke treatment
CorPath® telerobotic interventional platform has the potential to deliver timely, specialized cardiovascular treatment to remote, underserved patient populations across the globe.
Corindus Vascular Robotics, Inc. announced today that management will present at two investor conferences in November as follows
Advancing Development Programs for Remote Robotics and Neurovascular Applications
Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it will release financial and business results for the third quarter of 2018 on Tuesday, November 6, 2018
Corindus Announces First Live Transmission of Remote Robotic Demonstration Performed at Transcatheter Cardiovascular Therapeutics 2018 Conference
Live telerobotic procedure broadcast from Mayo Clinic to TCT Main Arena
Corindus Vascular Robotics, Inc. announced today that Mark Toland, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2018 Healthcare Conference
Corindus to Feature the CorPath® GRX System at the Transcatheter Cardiovascular Therapeutics 2018 Conference
Breakfast symposium and immersive booth activities highlight capabilities of vascular robotic technology and importance of remote access to care